Global equity in paediatric cancer care The Lancet Haematology ++... ++

Global equity in paediatric cancer care The Lancet Haematology https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00042-6/fulltext?dgcid=raven_jbs_etoc_email Mar 2026 Volume 13Number 3e119-e186 https://www.thelancet.com/journals/lanhae/issue/vol13no3/PIIS2352-3026(26)X2002-6 Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial Valentín Ortiz-Maldonado, MDa,e,f ∙ Núria Martínez-Cibrian, MDa,e,f ∙ Leticia Alserawan, BPharmb,e ∙ Marta Español-Rego, BPharmb,e ∙ Sergio Navarro-Velázquez, BScb,e ∙ Nil Albiol, MDa,e,f ∙ et al. https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00328-X/abstract?dgcid=raven_jbs_etoc_feature_lanhae Patient-reported outcomes in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia receiving standard chemotherapy plus quizartinib or placebo (QuANTUM-First): a global, randomised, placebo-controlled, phase 3 trial Esther N Olíva, MDa enoliva@gmail.com ∙ Francesco Cottone, PhDb ∙ Sudhir Unni, PhDc ∙ Anne Correges, MSd ∙ Jes B Hansen, MSe ∙ Xiaocong Li Marston, PhDf ∙ et al. https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00361-8/abstract?dgcid=raven_jbs_etoc_feature_lanhae